In summary, these findings indicate that Curcumol significantly inhibits CoCl2-induced glycolytic enhancement and EMT by restoring VHL expression and suppressing HIF-1α signaling, thereby reversing the hypoxia-driven malignant phenotype in CRC organoids. Here, HIF1A is linked to colorectal carcinoma.